Lumida
/CRMD
⌘K
CorMedix Inc

CorMedix Inc

CRMD
$7.83USD-1.70%-0.13 today

MARKET CAP

609.9M

P/E (TTM)

3.6x

FWD P/E

DAY RANGE

$8 – $8

52W RANGE

$6
$13

AI Summary

Stalk
Sell NowMedium

CRMD is entrenched in a Stage 4 decline with a clear sequence of lower highs and lower lows. Short-term trend and EMAs are sloping downward, and price is extended below moving averages without signs of exhaustion. The medium-term bias remains bearish, unsupported by any mean-reversion eligibility, justifying an immediate sell initiation into resistance at the declining EMA regime.

  • Q2 revenue $101.9M up 100% YoY; EPS $0.29 beat $0.25 consensus; EBITDA guidance raised to $125–140M
  • Median analyst price target $15 signals ~96% upside from current levels
  • Significant price swings highlight elevated volatility risk
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income